All In MedTech

Device Trial Radar · NCT04045431

Treatment of Knee Osteoarthritis With PAAG-OA

A Multi-centre Randomized, Controlled, Double-blind Clinical Investigation of Intra-articular Polyacrylamide Hydrogel in Subjects With Knee Osteoarthritis Followed by an Open Label Extension Study

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 238 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

238

Actual

Start

May 15, 2019

Primary completion

Oct 1, 2020

Study completion Mar 10, 2025

Sponsor

Lead sponsor
ConturaNot on our public-company list
Sponsor type
Industry
First posted
Aug 5, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, double-blind clinical investigation to compare the effectiveness of intra-articular polyacrylamide hydrogel (PAAG-OA) and a hyaluronic acid, Synvisc-One to induce symptomatic benefit in subjects with knee osteoarthritis.

Conditions

  • Osteoarthritis, Knee

Interventions

  • PAAG-OADevice

    Intra-articular injection of 6ml PAAG-OA in the target knee (incl. five (5) years follow-up) period.

  • Synvisc-OneDevice

    Intra-articular injection of 6ml Synvisc-One in the target knee

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Comparing one injection of PAAG-OA with one injection of Synvisc-One on pain over 6 months in subjects with knee osteoarthritisTime frame: 6 months

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • The Parker Institute

    Frederiksberg, Denmark

2 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.